Should Antipsychotic Polypharmacy Be Used for Patients with Schizophrenia and Related Psychoses?
出版信息
Can J Hosp Pharm. 2021 Spring;74(2):163-166. Epub 2021 Apr 1.
Abstract
摘要
相似文献
1
Should Antipsychotic Polypharmacy Be Used for Patients with Schizophrenia and Related Psychoses?精神分裂症及相关精神病患者是否应使用抗精神病药物联合治疗？
Can J Hosp Pharm. 2021 Spring;74(2):163-166. Epub 2021 Apr 1.
2
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.抗精神病药联合用药与精神分裂症患者自然原因死亡风险：基于人群的巢式病例对照研究。
J Clin Psychiatry. 2010 Feb;71(2):103-8. doi: 10.4088/JCP.08m04818yel. Epub 2009 Nov 3.
3
Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.抗精神病药物联合使用及其与精神分裂症患者代谢综合征的关系：一项埃及研究。
J Clin Psychopharmacol. 2018 Feb;38(1):27-33. doi: 10.1097/JCP.0000000000000815.
4
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.高剂量的抗精神病药物联合使用与精神分裂症患者血清中戊糖苷水平的升高有关。
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:42-48. doi: 10.1016/j.pnpbp.2017.02.019. Epub 2017 Mar 7.
5
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries.四个欧洲国家治疗的精神分裂症患者中联合使用多种药物及过量用药的持续性。
Int Clin Psychopharmacol. 2006 Nov;21(6):355-62. doi: 10.1097/01.yic.0000224785.68040.43.
6
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.非典型抗精神病药物对精神分裂症进行自然主义治疗中的抗精神病药物单一疗法与联合用药
BMC Psychiatry. 2005 May 27;5:26. doi: 10.1186/1471-244X-5-26.
7
Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital.尼日利亚一家医院精神分裂症门诊患者的抗精神病药物处方与联合用药情况
Niger Postgrad Med J. 2020 Jan-Mar;27(1):30-36. doi: 10.4103/npmj.npmj_93_19.
8
The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.将精神分裂症或分裂情感性障碍患者从两种抗精神病药物转换为一种抗精神病药物的风险与益处：一项随机对照试验。
Schizophr Res. 2015 Aug;166(1-3):194-200. doi: 10.1016/j.schres.2015.05.038. Epub 2015 Jun 30.
9
Antipsychotic polypharmacy in the treatment of schizophrenia in China and Japan.抗精神病药联合治疗在中国和日本治疗精神分裂症中的应用。
Aust N Z J Psychiatry. 2018 Dec;52(12):1202-1212. doi: 10.1177/0004867418805559. Epub 2018 Oct 12.
10
Description of long-term polypharmacy among schizophrenia outpatients.描述精神分裂症门诊患者的长期多种药物治疗情况。
Soc Psychiatry Psychiatr Epidemiol. 2013 Apr;48(4):631-8. doi: 10.1007/s00127-012-0586-6. Epub 2012 Sep 25.
本文引用的文献
1
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.抗精神病药物治疗急性精神分裂症的剂量-反应Meta 分析。
Am J Psychiatry. 2020 Apr 1;177(4):342-353. doi: 10.1176/appi.ajp.2019.19010034. Epub 2019 Dec 16.
2
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.循证指南：英国精神药理学协会更新的精神分裂症药物治疗推荐。
J Psychopharmacol. 2020 Jan;34(1):3-78. doi: 10.1177/0269881119889296. Epub 2019 Dec 12.
3
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.治疗抵抗性精神分裂症患者的特征、负担和药物治疗：来自对 204 名美国精神科医生的调查结果。
BMC Psychiatry. 2019 Nov 14;19(1):362. doi: 10.1186/s12888-019-2318-x.
4
The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.多药治疗的隐藏规模：使用限定日剂量和最大许可日剂量来衡量抗精神病药物负荷。
Int J Clin Pharm. 2019 Dec;41(6):1642-1651. doi: 10.1007/s11096-019-00930-3. Epub 2019 Nov 1.
5
Schizophrenia.精神分裂症
N Engl J Med. 2019 Oct 31;381(18):1753-1761. doi: 10.1056/NEJMra1808803.
6
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.抗精神病药联合治疗与单药治疗与成人精神分裂症患者精神科再入院的关联。
JAMA Psychiatry. 2019 May 1;76(5):499-507. doi: 10.1001/jamapsychiatry.2018.4320.
7
Barriers to using clozapine in treatment-resistant schizophrenia: systematic review.氯氮平用于难治性精神分裂症治疗的障碍：系统评价
BJPsych Bull. 2019 Feb;43(1):8-16. doi: 10.1192/bjb.2018.67. Epub 2018 Sep 28.
8
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.氯氮平延迟起始对治疗抵抗性精神分裂症患者治疗结局的影响：一项系统评价。
Psychiatry Res. 2018 Oct;268:114-122. doi: 10.1016/j.psychres.2018.06.070. Epub 2018 Jul 9.
9
Antipsychotic Combinations for Schizophrenia.用于精神分裂症的抗精神病药物联合治疗
Schizophr Bull. 2018 Jan 13;44(1):15-17. doi: 10.1093/schbul/sbx153.
10
Guidelines for the Pharmacotherapy of Schizophrenia in Adults.成人精神分裂症的药物治疗指南。
Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13.
Zotero 插件